NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Senesco Technologies, Inc. (“Senesco” or the “Company”) (AMEX: SNT) today announced that James W. Mier, M.D. has agreed to join the Company’s Scientific Advisory Board (“SAB”). Dr. Mier is both an Associate Professor of Medicine and a practicing physician in the Department of Hematology-Oncology at Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School. Dr. Mier’s research is funded by the NIH’s National Cancer Institute among others.
